Because Mdk was shown to negatively affect osteogenic differentiation based on an inhibition of the osteo-anabolic Wnt/β-catenin pathway [29,31], we next investigated in an in vitro approach whether the serum of fracture patients, in which we found increased Mdk serum levels, might influence osteogenic differentiation of human MSCs. This evidence concerns the gene MDK and bone fracture.